Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Healthtrust
Julphar
Farmers Insurance
Colorcon
Express Scripts
US Department of Justice
Covington
Johnson and Johnson
Fish and Richardson

Generated: August 21, 2017

DrugPatentWatch Database Preview

Phenmetrazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phenmetrazine hydrochloride and what is the scope of phenmetrazine hydrochloride patent protection?

Phenmetrazine hydrochloride
is the generic ingredient in one branded drug marketed by Boehringer Ingelheim and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: phenmetrazine hydrochloride

Tradenames:1
Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list10
Clinical Trials: see list2,260
Patent Applications: see list997
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phenmetrazine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
PRELUDIN
phenmetrazine hydrochloride
TABLET, EXTENDED RELEASE;ORAL011752-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Boehringer Ingelheim
PRELUDIN
phenmetrazine hydrochloride
TABLET;ORAL010460-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Boehringer Ingelheim
PRELUDIN
phenmetrazine hydrochloride
TABLET, EXTENDED RELEASE;ORAL011752-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
QuintilesIMS
Chubb
Citi
Johnson and Johnson
McKesson
Novartis
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot